Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for 2021.
For this series, the doctors discuss new trials for patients with NSCLC. In this video, the doctors discuss Carbo/Pemetrexed/Pembro in EGFRm+ or ALK+ NSCLC Acquired Resistance to Targeted Therapy
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.